Background: Between 1975 and 1987, 128 patients with infiltrating breast cancer, categorized as clinical Stage I and II disease, were treated by breast conservation surgery without radiation therapy.

Materials: After a median disease-free interval of 20 months (range, 8-64 months), 25 of 128 patients had local recurrence, for which salvage mastectomy was performed. The results of modified radial mastectomy as a salvage procedure were analyzed in these 25 patients.

Results: After a median disease-free interval of 52 months (range, 8-75 years) after the salvage procedure, 12 patients had chest wall and distant recurrences, whereas 13 patients remained free of disease. The 5-year actuarial disease-free and overall survival rates after the salvage mastectomy were 51% and 65%, respectively.

Conclusions: Univariate analyses of factors affecting disease-free survival and overall survival showed that the size of the local recurrence (< or = 2 cm) (P = 0.009) and the number of pathologically positive axillary nodes at the time of the salvage procedure (fewer than four nodes) (P = 0.002) were associated with a better prognosis.

Download full-text PDF

Source
http://dx.doi.org/10.1002/1097-0142(19930301)71:5<1774::aid-cncr2820710511>3.0.co;2-vDOI Listing

Publication Analysis

Top Keywords

salvage mastectomy
12
local recurrence
12
salvage procedure
12
surgery radiation
8
128 patients
8
median disease-free
8
disease-free interval
8
interval months
8
months range
8
disease-free survival
8

Similar Publications

Article Synopsis
  • The study examines complications related to immediate breast reconstruction after mastectomy in patients with and without postmastectomy radiotherapy (PMRT), comparing pre-pectoral and subpectoral implant placements.
  • Out of 3,039 patients reviewed between 2005 and 2020, 815 met the criteria for analysis, with a follow-up of 6.2 years, showing no significant differences in major complications between the two implant placements.
  • The results indicated that while there was no notable difference in infection or reconstruction failures between proton and photon therapies, patients undergoing proton therapy had a higher risk of capsular contracture and overall reconstruction failure.
View Article and Find Full Text PDF

Fam-trastuzumab deruxtecan (T-DXd) has demonstrated substantial antitumor activity and durable responses in patients with human epidermal growth factor receptor 2 positive (HER2+) metastatic breast cancer. We report here the treatment outcomes of T-DXd in a patient with HER2+ breast cancer with brain metastases that repeatedly recurred and progressed after two lines of salvage therapy. In 2016, a 23-year-old G0P0 female with risk factors including menarche at age 9 years, Li-Fraumeni syndrome, and a strong family history of cancer was diagnosed with bilateral, triple-positive breast cancer.

View Article and Find Full Text PDF

Introduction: Free flap surgery is a reliable and safe procedure for breast reconstruction. The survival of free flaps depends on their vascular pedicle initially, but neovascularization can sustain their blood supply after a while. Management of late pedicle occlusion in free flap breast reconstruction and potential implications of late pedicle occlusion on the transferred tissue are controversial.

View Article and Find Full Text PDF

Background/aim: Breast-conserving surgery is the preferred treatment for early-stage breast cancer but can often result in unsatisfactory cosmetic outcomes. Oncoplastic surgery aims to improve both oncologic and aesthetic outcomes by combining local excision with plastic surgery techniques. Using breast reduction techniques in breast cancer treatment has been shown to allow for wider margins of excision, leading to enhanced oncological safety and reduced recurrence rates without causing significant asymmetry.

View Article and Find Full Text PDF

Management of the Infected Tissue Expander.

Plast Reconstr Surg

October 2024

Plastic and Reconstructive Surgery Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.

Background: Tissue expander (TE) infection is a critical postoperative complication in two-stage implant-based breast reconstruction (IBBR). We assessed risk factors associated with TE infection and reconstructive loss and examined reconstructive salvage rates.

Methods: We retrospectively reviewed patients who underwent IBBR with TE placement from 2017 to 2022.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!